Interleukin-6 serum levels in patients with multiple myeloma.
Studying the prognostic value of serum interleukin-6 (IL-6) levels in multiple myeloma, we observed important daily variations in some patients. Therefore a unique serum IL-6 measurement should be interpreted with caution and requires confirmation by multiple determinations performed over a period of several days.
Emile
C
C
Immunology and Immunopathology Department, Hôpital Saint-Louis, Paris, France.
Fermand
J P
JP
Danon
F
F
D001681:Biological Assay; D014408:Biomarkers, Tumor / Q000097:blood; D002940:Circadian Rhythm / Q000502:physiology*; D006801:Humans; D015850:Interleukin-6 / Q000097:blood*; D009101:Multiple Myeloma / Q000097:blood*
D014408:Biomarkers, Tumor; D015850:Interleukin-6